O-3 Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001)

Authors:
  • MPM. Patel
    M. Patel
  • SSS. Siena
    S. Siena
  • GDG. Demetri
    G. Demetri
  • RDR. Doebele
    R. Doebele
  • YCY. Chae
    Y. Chae
  • PCP. Conkling
    P. Conkling
  • IGI. Garrido-Laguna
    I. Garrido-Laguna
  • FLF. Longo
    F. Longo
  • CRC. Rolfo
    C. Rolfo
  • DSD. Sigal
    D. Sigal
  • ADA. Drilon
    A. Drilon
  • SLS. Liu
    S. Liu

Abstract
No abstract available
Funding Information
  • F. Hoffmann-La Roche